Standard Chartered PLC Share Price Today: Stock Slips Despite Fresh Buyback and Citi Hire

Standard Chartered PLC Share Price Today: Stock Slips Despite Fresh Buyback and Citi Hire

March 27, 2026

LONDON, March 27, 2026, 11:02 GMT

Standard Chartered shares slipped 1.5% in London by 1102 GMT on Friday, coming in at 1,530.75 pence. That move builds on Thursday’s 3.95% drop, capping off a choppy week for the stock. Year-to-date, shares have shed 15.6%, still a far cry from the 19.24-pound high set back on Feb. 3. MarketScreener

The timing isn’t ideal for the bank. Investors are trying to figure out if capital returns and a bigger investment-banking footprint can counter concerns about Middle East exposure, made sharper by the wave of management shakeups after February’s sudden CFO departure. J.P. Morgan analysts pointed out earlier this month that Standard Chartered and HSBC top the list of European banks with the largest exposure to the region’s turmoil. For StanChart, that’s roughly 8% of revenue and 12% of pretax profit tied to the Middle East, they estimate. Reuters

Standard Chartered picked up 942,750 of its own shares on March 26 for £14.8 million, according to a Hong Kong filing reported by Reuters on Friday. The bank’s buyback activity has kept a similar beat all week: Reuters previously flagged 945,698 shares bought on March 25, and 952,044 the day before. MarketScreener

Standard Chartered is bringing in more senior dealmakers. Jan Metzger, currently Citigroup’s co-head of Asia investment banking, will start in July as global head of coverage banking, the bank said. Metzger will be based in Hong Kong, reporting to Roberto Hoornweg. Reuters reported he’s exiting Citi after eight years in the regional post. Reuters

Hoornweg pointed to “a global client-first mindset, relentless execution and assembling the best talent” as key to the bank’s success, saying Metzger’s arrival should “accelerate the momentum” across its franchise. The move lines up with Bill Winters’ strategy of leaning harder into fee-generating business and advisory. Standard Chartered Bank

Standard Chartered has put that strategy front and center. Back in February, the bank logged a pretax profit of $6.96 billion for the full year—16% higher, but still shy of the $7.2 billion analysts had penciled in. Along with the results, it unveiled a $1.5 billion buyback and said the full-year dividend would jump 65%. CEO Bill Winters noted at the time, “the board has also been clear they would like me to see through this strategy.” Meanwhile, investor relations chief Manus Costello pointed out that business volumes between China and Southeast Asia climbed 20% last year, with China-Middle East flows up 18% and China-Africa up 25%. Reuters

Morningstar’s Kathy Chan points to “increased economic uncertainty” as a potential source of extra risk for the Group’s trade finance and credit costs. Still, disruption isn’t all bad news—Hargreaves Lansdown’s Matt Britzman notes it can actually push up demand for foreign exchange and cash-management services. Reuters, meanwhile, highlights that JPMorgan and Citi are both ramping up in the Gulf, a sign of fierce competition in the region. Reuters

First-quarter results drop April 30. Eyes will be on whether the buyback and the push into investment banking are showing up in more consistent earnings—and whether geopolitical tensions have started to push up credit costs or drag on client activity. Standard Chartered Bank

Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

Stock Market Today

  • Pro Medicus Stock Soars Post Echo IQ Deal, Valued at A$1 Billion
    June 26, 2026, 4:15 PM EDT. Pro Medicus (ASX:PME) closed at A$188.88 on June 26, rising 1.9% on the day and 9.3% over the week, fueled by a deal with Echo IQ (ASX:EIQ) valued at A$20 million but generating an effective market cap increase of approximately A$1.03 billion. This deal involves a proposed U.S. reseller agreement for EchoSolv AI tools, with final legal documents expected within 20 business days. Echo IQ will receive A$10 million in secured convertible notes initially, paying 12.5% interest, secured by AI cardiovascular algorithms. The surge reflects investor confidence in Pro Medicus leveraging Visage 7 Cardiology software to expand into AI distribution. Despite being dropped from the S&P/ASX 50 index, the stock gains suggest strong sector interest amid broader market stagnation.